Trial record 1 of 1 for:
EWALL-BOLD | All | Germany
Treatment of Older Patients With B-precursor ALL With Sequential Dose Reduced Chemotherapy and Blinatumomab (EWALL-BOLD)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03480438 |
|
Recruitment Status :
Recruiting
First Posted : March 29, 2018
Last Update Posted : July 29, 2020
|
Sponsor:
Goethe University
Information provided by (Responsible Party):
Nicola Goekbuget, Goethe University
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Recruiting |
|---|---|
| Estimated Primary Completion Date : | September 1, 2022 |
| Estimated Study Completion Date : | January 1, 2023 |